Bitter Suit Over Research Work Asks 'Who Deserves The Credit?'

First she was his student, a medical resident working under an internationally recognized expert in the field of nuclear medicine. Then she was his academic and clinical colleague, making her way as a re spected scientist. Finally, after 10 years m the lab, Heidi S. Weissmann became the plaintiff, and Leonard M. Freeman the defendant, in a bitter and costly legal dispute that touches on one of the pillars of the research enterprise: assigning credit for original work. In February, weissman

Written byJeffrey Mervis
| 11 min read

Register for free to listen to this article
Listen with Speechify
0:00
11:00
Share

First she was his student, a medical resident working under an internationally recognized expert in the field of nuclear medicine. Then she was his academic and clinical colleague, making her way as a re spected scientist. Finally, after 10 years m the lab, Heidi S. Weissmann became the plaintiff, and Leonard M. Freeman the defendant, in a bitter and costly legal dispute that touches on one of the pillars of the research enterprise: assigning credit for original work.

In February, weissmann gained the advantage after a three-judge appellate court reversed a lower court decision that denied her claim of authorship on a disputed paper. At this point, Freeman is hoping to persuade the appellate court to review the case; if he succeeds, the 18-monthold case could be extended for several more months.

But Weissmann v. Freeman isn’t simply a spat within a department of academic medicine, or even one more ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies